Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
FASEB J ; 22(4): 1237-45, 2008 Apr.
Article in English | MEDLINE | ID: mdl-18048579

ABSTRACT

We constructed a single-chain variable fragment miniantibody (G11-scFv) directed toward the transactivation domain of c-Myc, which is fused with the internalization domain Int of Antennapedia at its carboxyl terminus (a cargo-carrier construct). In ELISA experiments, an EC(50) for binding saturation was achieved at concentrations of G11-scFv-Int(-) of approximately 10(-8) M. Internalization of a fluoresceinated Fl-G11-scFv-Int(+) construct was observed in intact human cultured cells with confocal microscopy. After 5 h of incubation in medium containing 1 microM Fl-G11-scFv-Int(+) or Fl-G11-scFv-Int(-), fluorescence intensity was determined in individual cells, both for cytoplasmic and nuclear compartments: concentration levels of Fl-G11-scFv-Int(+), relative to the extracellular culture medium concentration, were 4-5 times higher in the cytoplasm, 7-8 times higher in the nucleus, and 10 times higher in the nucleoli. In the same experimental conditions, the Fl-G11-scFv-Int(-) construct was 3-4 times more concentrated outside of the cells than inside. Cell membranes kept their integrity after 5 h of incubation. The antiproliferative activity of our miniantibody was studied on HCT116 cells. Incubation with 4 microM G11-scFv-Int(+) for 4 days induced very significant statistical and biological growth inhibition, whereas Int alone was completely inactive. Miniantibodies capable of penetrating cell membranes dramatically broaden the potential for innovative therapeutic agents and attack of new targets.


Subject(s)
Antennapedia Homeodomain Protein/chemistry , Antibodies, Monoclonal/metabolism , Immunoglobulin Variable Region/metabolism , Proto-Oncogene Proteins c-myc/antagonists & inhibitors , Antibodies, Monoclonal/genetics , Antibodies, Monoclonal/immunology , Cell Nucleus/metabolism , HCT116 Cells , Humans , Immunoglobulin Variable Region/genetics , Immunoglobulin Variable Region/immunology , Protein Structure, Tertiary , Proto-Oncogene Proteins c-myc/immunology , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism
2.
FASEB J ; 21(4): 1256-63, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17215484

ABSTRACT

c-Myc is a transcription modulator proto-oncogene. When overexpressed, it becomes an important contributor to the multi-hit process of malignant transformation. In two earlier papers in this journal (see refs. 19 , 20) we reported that retro-inverso peptidomimetic molecules inspired by the Helix-1 of c-Myc motif could be sequence-specific antiproliferative agents active in the low micromolar range. We also found that our peptides were not opening the four-alpha-helix Myc:Max bundle. Their antiproliferative activity in cancer cell lines needs the presence of side chains projecting outside of the bundle in the corresponding native H1 motif. This observation suggested interference with an external partner. In this study we investigated the INI1:Myc interaction. INI1 is a subunit of the SWI/SNF complex (component of the enhanceosome surrounding Myc:Max heterodimer). The INI1:Myc interaction was confirmed via pull down, ELISA, and fluorescence anisotropy assays. According to the length of INI1 fragments used, we calculated Kds ranging between 1.3x10(-6) and 4.8x10(-7) M. The three different techniques applied showed that the INI1:Myc interaction was also the target of our retro-inverso peptidomimetic molecules, which seem to bind specifically at INI1. A Myc binding, 21aa INI1 fragment (minimum interacting sequence), could inspire the synthesis of a new class of more selective c-Myc inhibitors.


Subject(s)
Antineoplastic Agents/pharmacology , Chromosomal Proteins, Non-Histone/chemistry , DNA-Binding Proteins/chemistry , Neoplasms/metabolism , Peptides/chemistry , Protein Interaction Mapping , Proto-Oncogene Proteins c-myc/chemistry , Transcription Factors/chemistry , Amino Acid Sequence , Anisotropy , Biochemistry/methods , Humans , Kinetics , Microscopy, Fluorescence , Molecular Sequence Data , Neoplasms/drug therapy , Protein Conformation , Protein Structure, Secondary , Proto-Oncogene Mas , SMARCB1 Protein
SELECTION OF CITATIONS
SEARCH DETAIL
...